Eric Pierre Guenin PharmD PhD MPH

Directed medical strategy development for brodalumab in psoriasis, overseeing publications and advisory boards.

Led prelaunch and post-launch initiatives for acne, atopic dermatitis, and onychomycosis treatments to align with medical and marketing strategies.

Participated in promotional review committee to evaluate and approve promotional materials.

Monitored competitor activities to identify clinical trial threats to commercial units.

• Assessed product opportunities to support broader business development strategies.
• Cultivated expert network to strengthen strategic collaborations.
• Collaborated with medical liaison team to inform ortho-dermatologics personnel of recent developments.

• Designed research projects for pharmacy rotation students and Pharm.D. fellows.
• Guided students in completing final training reports to ensure thorough understanding.
• Trained and coached students to enhance practical pharmacy skills throughout the program.

• Led medical affairs team for respiratory and dermatology franchises, overseeing advisory boards and publication strategies.
• Managed podium and poster presentations at national and international conferences.
• Directed pharmacovigilance efforts during product recalls, conducting investigations of adverse events.
• Facilitated collaboration with academic centers to enhance medical education programs.
• Trained sales teams across major retailers, including Walmart and Walgreens, on product knowledge.
• Developed comprehensive training materials, including a web-based application for remote learning.
• Reviewed advertising and professional detailing materials to ensure medical accuracy.
• Established product complaint review committee for OTC products to document internal investigations.

• Developed long-term clinical strategy for Novartis products in collaboration with marketing and medical affairs.
• Led due diligence for business opportunities and evaluated external technologies.
• Created scientific dossiers and presentations for clinical expert reviews of portfolio products.
• Participated in international professional meetings while maintaining contact with key experts.
• Served as medical representative on professional clinical task force.
• Managed clinical trials for Novartis drug products with a focus on line extensions.
• Represented clinical interests in NDA and ANDA meetings with health authorities (FDA, MHRA, MPA, ANVISA, BfArM).
• Reviewed operational metrics and directed development of tools to enhance clinical trial execution.

• Directed medical affairs for dermatology brands, including Benzaclin and Sculptra.
• Collaborated with head of medical category to provide strategic leadership for post-approval initiatives.
• Developed comprehensive medical affairs strategic plans, ensuring alignment with tactical initiatives.
• Managed medical affairs budget, adhering to OIG, ACCME, and AMA guidelines.
• Coordinated budget reviews with purchasing and finance; presented programs at review committee meetings.
• Oversaw development and execution of Phase IV clinical trial programs.
• Formulated educational strategies for evaluating grants and investigator-initiated studies.
• Organized advisory boards with key opinion leaders focusing on various dermatological conditions.

• Developed clinical documentation for new OTC products, aligning with global customer needs.
• Managed full-time scientists, setting objectives and conducting performance appraisals.
• Coordinated development activities, including packaging engineering and formulation clinical trials.
• Led the development and launch of dermatological and OTC products to market.
• Established an internship program with Rutgers University to foster talent development.